Tumor Bank for Blood Samples
Conditions
Ovarian Neoplasms - Breast Neoplasms - Colorectal Neoplasms - Neoplasms of the Female Genitalia - Lung Neoplasms - Endocrine Gland Neoplasms
Conditions: official terms
Breast Neoplasms - Colorectal Neoplasms - Endocrine Gland Neoplasms - Lung Neoplasms - Neoplasms - Ovarian Neoplasms
Conditions: Keywords
Breast cancer, Ovarian cancer, Endometrium carcinoma, Cervix carcinoma,, Mamma carcinoma,, Prostata carcinoma, Colon carcinoma, Rectal carcinoma, Bronchus carcinoma, NSCLC & SCLC (Non Small Cell Lung Cancer & Small Cell Lung Cancer)), Prostate carcinoma
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case Control
Intervention
Name: Blood collection
Type: Other
Overall Status
Recruiting
Summary
Establishment of a tumor bank, consisting of blood samples of tumor patients and healthy people as controls. The blood samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank.
Detailed Description
Recent progress in diagnosis and therapy of cancer diseases can be ascribed mainly to translational research. The relevance of "translational oncology" will only increase in the future -"From bench to bedside" - the swift implementation of new science research results in clinical studies in order to expedite progress in clinical cancer therapy for the benefit of the patient.

Its almost a matter of course in the medical science today to collect biological samples together with clinical information thereby creating the foundation for future excellent fundamental research.

The aim of this tumor bank is to consist of biological samples (together with a tissue bank - see EK 260/2003) and isolates of tumor patients and healthy people as controls. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank. The content of the tumor bank can provide essential material for current and future research (e.g. analyses of prognostic or predictive tumor markers; genetically analysis (polymorphism, mutation, hypermethylation; verification and characterisation of disseminated tumor cells).
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Male/Female

- Age 18 to 90 years max.

- Just one current known malignant disease or

- Just one current inflammatory disease

Exclusion Criteria:

- Inflammatory disease and malignant disease

- multiple malignancies

- multiple diseases

- underage
Locations
Innsbruck Medical University
Innsbruck, Austria
Status: Not yet recruiting
Contact: Nicole Concin, Prof.Dr. - +43 50-504-0 - nicole.concin@i-med.ac.at
University Hospitals Leuven - Department of Obstetrics and Gynaecology
Leuven, Belgium
Status: Recruiting
Contact: Ignace Vergote, Prof.Dr. - +32/1634 - ignace.vergote@uzleuven.be
University Hospital Motol, Charles University, Dpt of Obstet. & Gynaec.
Praha, Czech Republic
Status: Active, not recruiting
Charité University - Campus Virchow Chlinic
Berlin, Germany
Status: Recruiting
Contact: Jalid Sehouli, Prof.Dr. - Jalid.Sehouli@charite.de
University Medical Center Freiburg
Freiburg, Germany
Status: Recruiting
Contact: Annette Hasenburg, Prof. Dr. - +49 761 270 - annette.hasenburg@uniklinik-freiburg.de
University Clinic of Ruhr University Bochum
Herne, Germany
Status: Recruiting
Contact: Clemens B Tempfer, Prof.Dr.PhD. - clemens.tempfer@marienhospital-herne.de
European Institute of Oncology, Division of Gynecologic Oncology, Unit of Preventive Gynecology
Milan, Italy
Status: Recruiting
Contact: Michele Peiretti - +36 2 57489543 - michele.peiretti@ieo.it
Imperial College London - Faculty of Medicine, Dpt. of Surgery & Cancer
London, United Kingdom
Status: Recruiting
Contact: Hani Gabra, Prof.Dr. - +44 (0)20 3313 - h.gabra@imperial.ac.uk
Start Date
November 2003
Completion Date
January 2017
Sponsors
Medical University of Vienna
Source
Medical University of Vienna
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page